Innodem Neurosciences

medical devices

About

Innodem Neurosciences is committed to improving the effectiveness and quality of life and care of patients with neurological problems. Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer's, Parkinson's or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.

Technologies

Gmail Google Apps Google Font API Google Maps (Non Paid Users) Mobile Friendly Shopify Google Maps Remote AI

Keywords

gaze tracking technology & mobile communication applications mobile communication applications gaze tracking technology medical equipment manufacturing digital biomarker machine learning algorithms neuroplasticity regulatory review visual tasks analysis eye tracking neuroinflammation tablet-based eye tracking neuroimaging cognitive function etna-ms medical devices neurodegenerative diseases biotechnology gaze-to-speech healthcare b2b gaze mapping biomarkers biomarker development non-invasive neurological assessment ai medical and diagnostic laboratories services healthcare technology pharmaceuticals clinical trials

Location

6666 Rue St-Urbain, Montreal, Quebec, Canada, H2S 3H1

Related Companies

Companies in the same industry